AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36097716 — intervention group
Group type: COMPARATOR
Intervention: Low controlling language, low fear, and low disgust appeals
Number of subjects: 0
Study 34636974 — intervention group
Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided antibiotic therapy (PCT group)
Number of subjects: 159
Study 34636974 — intervention group
Group type: COMPARATOR
Intervention: Control group (antibiotic therapy managed at physician’s discretion)
Number of subjects: 159
Study 36171048 — intervention group
Group type: EXPERIMENTAL
Intervention: Research questions formatted using the PICO structure submitted by stakeholders
Number of subjects: 0
Study 32777945 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium intake (highest vs. lowest quartile)
Number of subjects: 991
Study 32777945 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc intake (highest vs. lowest quartile)
Number of subjects: 991
Study 32777945 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined effect of zinc and SOD1 rs4998557
Number of subjects: 991
Study 34108397 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically instrumented hearing loss
Number of subjects: 129731
Study 34108397 — intervention group
Group type: EXPERIMENTAL
Intervention: Major depression
Number of subjects: 129731
Study 34108397 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroticism
Number of subjects: 129731
Study 34108397 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher systolic blood pressure
Number of subjects: 129731
Study 34108397 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer duration in education
Number of subjects: 129731
Study 34108397 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher caffeine intake
Number of subjects: 129731
Study 34108397 — intervention group
Group type: EXPERIMENTAL
Intervention: Being a morning person
Number of subjects: 129731
Study 34108397 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetic liability to neuroticism
Number of subjects: 129731
Study 34108397 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetic liability to schizophrenia
Number of subjects: 129731
Study 33247395 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive distraction technique
Number of subjects: 48
Study 33247395 — intervention group
Group type: COMPARATOR
Intervention: Control group (no interactive distraction)
Number of subjects: 48
Study 33247395 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group (interactive distraction)
Number of subjects: 48
Study 32066726 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Awareness Practice (MAP)
Number of subjects: 55
Study 32066726 — intervention group
Group type: COMPARATOR
Intervention: Health Education Program (HEP)
Number of subjects: 55
Study 35086778 — intervention group
Group type: EXPERIMENTAL
Intervention: SCT (umbilical cord mesenchymal stromal cells plus autologous bone marrow mononuclear cells)
Number of subjects: 21
Study 33482787 — intervention group
Group type: EXPERIMENTAL
Intervention: Park Prescription Intervention (PPI) including baseline counselling, exercise prescription in parks, materials, three-month follow-up counselling, and 26 weekly group exercise sessions in parks.
Number of subjects: 160
Study 33482787 — intervention group
Group type: EXPERIMENTAL
Intervention: Park PA at three months
Number of subjects: 160
Study 33482787 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 160
Study 32205521 — intervention group
Group type: EXPERIMENTAL
Intervention: Ideal OC2A and POCA postoperatively immediately after surgery and ambulation in BI group (26 patients).
Number of subjects: 150
Study 32205521 — intervention group
Group type: COMPARATOR
Intervention: Ideal angle group in BI group.
Number of subjects: 150
Study 32205521 — intervention group
Group type: EXPERIMENTAL
Intervention: Ideal angle group in AAFD group (20 patients).
Number of subjects: 150
Study 32205521 — intervention group
Group type: COMPARATOR
Intervention: Nonideal angle group in BI group.
Number of subjects: 150
Study 32205521 — intervention group
Group type: COMPARATOR
Intervention: Nonideal angle group in AAFD group.
Number of subjects: 150
Study 35847436 — intervention group
Group type: EXPERIMENTAL
Intervention: GM142 (newly developed gelatin film)
Number of subjects: 146
Study 35847436 — intervention group
Group type: COMPARATOR
Intervention: Conventional film (hyaluronate‐carboxymethylcellulose)
Number of subjects: 146
Study 35847436 — intervention group
Group type: EXPERIMENTAL
Intervention: GM142
Number of subjects: 146
Study 35847436 — intervention group
Group type: COMPARATOR
Intervention: GM142 and Conventional film
Number of subjects: 146
Study 34856936 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab combined with cisplatin-gemcitabine
Number of subjects: 0
Study 34856936 — intervention group
Group type: EXPERIMENTAL
Intervention: Avelumab combined with dose-dense methotrexate-vinblastine-doxorubicin-cisplatin
Number of subjects: 0
Study 34856936 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-gemcitabine associated with avelumab
Number of subjects: 0
Study 34856936 — intervention group
Group type: COMPARATOR
Intervention: Avelumab alone
Number of subjects: 0
Study 32970315 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination tablet containing 75-mg clopidogrel and 100-mg enteric ASA
Number of subjects: 0
Study 32970315 — intervention group
Group type: COMPARATOR
Intervention: Coadministration of one 75-mg clopidogrel tablet and one 100-mg enteric-coated ASA tablet
Number of subjects: 0
Study 35135384 — intervention group
Group type: EXPERIMENTAL
Intervention: GEP‐DT (Gear exercise programme repeated at different times during the day): cycled for 90 seconds, repeated three times per day, three days per week.
Number of subjects: 0
Study 35135384 — intervention group
Group type: EXPERIMENTAL
Intervention: GEP‐OT (Gear exercise programme repeated at one point in time): cycled for 90 seconds followed by four minutes and 30 seconds rest, repeated three times at one point in time, three days per week.
Number of subjects: 0
Study 35135384 — intervention group
Group type: EXPERIMENTAL
Intervention: MICE (Moderate-intensity continuous exercise group): cycled for 30 minutes at 55-69% of HRmax.
Number of subjects: 0
Study 35135384 — intervention group
Group type: COMPARATOR
Intervention: CTRL (Control group): did not exercise.
Number of subjects: 0
Study 34163152 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% FiO2 (group A)
Number of subjects: 662
Study 34163152 — intervention group
Group type: COMPARATOR
Intervention: 80% FiO2 (group B)
Number of subjects: 662
Study 32706883 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormonal treatment (HT)
Number of subjects: 151
Study 32706883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study 35284778 — intervention group
Group type: EXPERIMENTAL
Intervention: Emicizumab 1.5 mg/kg once weekly (arm A)
Number of subjects: 70
Study 35284778 — intervention group
Group type: EXPERIMENTAL
Intervention: Emicizumab 6 mg/kg every 4 weeks (arm B)
Number of subjects: 70
Study 35284778 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis (arm C)
Number of subjects: 70
Study 34678585 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA oral daily supplementation
Number of subjects: 60
Study 34678585 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily supplementation
Number of subjects: 60
Study 35022839 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezo-assisted turbinoplasty with bipolar coagulation
Number of subjects: 100
Study 35022839 — intervention group
Group type: COMPARATOR
Intervention: Partial turbinectomy with bipolar coagulation
Number of subjects: 100
Study 35022839 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezo-assisted turbinoplasty
Number of subjects: 100
Study 35022839 — intervention group
Group type: COMPARATOR
Intervention: Partial turbinectomy
Number of subjects: 100
Study 33023802 — intervention group
Group type: EXPERIMENTAL
Intervention: Curettage with cortical perforations
Number of subjects: 28
Study 33023802 — intervention group
Group type: COMPARATOR
Intervention: Standard curettage (Control)
Number of subjects: 28
Study 34482179 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomuzotuximab (initial dose 990 mg then 720 mg) weekly with cisplatin 100 mg/m2 and fluorouracil (5-FU; 1000 mg/m2/day, days 1-4) every 3 weeks
Number of subjects: 240
Study 34482179 — intervention group
Group type: COMPARATOR
Intervention: Cetuximab (400 mg/m2 subsequent 250 mg/m2) weekly with the same chemotherapeutic backbone
Number of subjects: 240
Study 32277635 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic complete mesocolic excision (CME)
Number of subjects: 196
Study 32277635 — intervention group
Group type: COMPARATOR
Intervention: Traditional radical operation
Number of subjects: 196
Study 35970202 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking
Number of subjects: 1780
Study 35970202 — intervention group
Group type: COMPARATOR
Intervention: Early cord clamping
Number of subjects: 1780
Study 34379119 — intervention group
Group type: EXPERIMENTAL
Intervention: PreLiFe-programme (mobile application with motivational interviewing every three months)
Number of subjects: 0
Study 34379119 — intervention group
Group type: COMPARATOR
Intervention: Attention-control group
Number of subjects: 0
Study 32672665 — intervention group
Group type: EXPERIMENTAL
Intervention: 9% SH-containing toothpaste (SHCT)
Number of subjects: 40
Study 32672665 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% SH-containing toothpaste (SHCT)
Number of subjects: 40
Study 32672665 — intervention group
Group type: COMPARATOR
Intervention: 0% SH-containing toothpaste (SHCT)
Number of subjects: 40
Study 32672665 — intervention group
Group type: COMPARATOR
Intervention: 6% SH-containing toothpaste (SHCT)
Number of subjects: 40
Study 36124513 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga with dietary modification
Number of subjects: 165
Study 36124513 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard weight management
Number of subjects: 165
Study 36124513 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 165
Study 34493307 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored text messages (GHSH)
Number of subjects: 228
Study 34493307 — intervention group
Group type: COMPARATOR
Intervention: No additional contact (control group)
Number of subjects: 228
Study 32725875 — intervention group
Group type: EXPERIMENTAL
Intervention: Caphosol
Number of subjects: 56
Study 32725875 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 56
Study 32725875 — intervention group
Group type: EXPERIMENTAL
Intervention: Caphosol and Saline
Number of subjects: 56
Study 35438265 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct composite restorations with a short fiber‐reinforced base (SFCRs)
Number of subjects: 18
Study 35438265 — intervention group
Group type: COMPARATOR
Intervention: Indirect glass‐ceramic endocrowns (GCEs)
Number of subjects: 18
Study 33483897 — intervention group
Group type: EXPERIMENTAL
Intervention: Viral Combat (iPhone game)
Number of subjects: 69
Study 33483897 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 69
Study 32280099 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical periodontal markers (Attachment Loss, probing pocket depth) and bacterial markers (pathogen immunoglobulin G)
Number of subjects: 0
Study 35040416 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-low-dose group (32 cases)
Number of subjects: 64
Study 35040416 — intervention group
Group type: COMPARATOR
Intervention: Low-dose group (32 cases)
Number of subjects: 64
Study 33351886 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded retainer 13-23
Number of subjects: 90
Study 33351886 — intervention group
Group type: EXPERIMENTAL
Intervention: Bonded retainer 12-22
Number of subjects: 90
Study 33351886 — intervention group
Group type: EXPERIMENTAL
Intervention: Removable vacuum-formed retainer (VFR)
Number of subjects: 90
Study 34047716 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG with electrolyte (50 mL/kg) and oral bisacodyl (PEG+B group)
Number of subjects: 129
Study 34047716 — intervention group
Group type: COMPARATOR
Intervention: PEG with electrolyte (70 mL/kg) and glycerol enema (PEG+G group)
Number of subjects: 129
Study 34047716 — intervention group
Group type: COMPARATOR
Intervention: PEG+G group
Number of subjects: 129
Study 34047716 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG+B group
Number of subjects: 129
Study 34481521 — intervention group
Group type: EXPERIMENTAL
Intervention: Over-the-head position
Number of subjects: 25
Study 34481521 — intervention group
Group type: EXPERIMENTAL
Intervention: Straddle position
Number of subjects: 25
Study 34481521 — intervention group
Group type: COMPARATOR
Intervention: Standard position (control)
Number of subjects: 25
Study 32341187 — intervention group
Group type: EXPERIMENTAL
Intervention: Daridorexant 10 mg
Number of subjects: 58
Study 32341187 — intervention group
Group type: EXPERIMENTAL
Intervention: Daridorexant 25 mg
Number of subjects: 58
Study 32341187 — intervention group
Group type: EXPERIMENTAL
Intervention: Daridorexant 50 mg
Number of subjects: 58
Study 32341187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 35960814 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Er:YAG laser and Nd:YAG laser treatment
Number of subjects: 30
Study 35960814 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 30
Study 34366004 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex interprofessional intervention including drug review by pharmacists, educational sessions for general practitioners and nurses, a drug safety toolbox, and change management seminars for 23 nursing homes with 452 residents.
Number of subjects: 862
Study 34366004 — intervention group
Group type: COMPARATOR
Intervention: Usual care provided in 21 nursing homes with 410 residents.
Number of subjects: 862
Study 34366004 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex interprofessional intervention
Number of subjects: 862
Study 34366004 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 862
Study 34919884 — intervention group
Group type: EXPERIMENTAL
Intervention: 79.2 Gy of EBRT over 44 fractions
Number of subjects: 1532
Study 34919884 — intervention group
Group type: COMPARATOR
Intervention: 70.2 Gy of EBRT over 39 fractions
Number of subjects: 1532
Study 33545941 — intervention group
Group type: EXPERIMENTAL
Intervention: Herb-partitioned moxibustion plus lifestyle modification treatment
Number of subjects: 108
Study 33545941 — intervention group
Group type: COMPARATOR
Intervention: Heat application group
Number of subjects: 108
Study 33545941 — intervention group
Group type: COMPARATOR
Intervention: Medicated plaster group
Number of subjects: 108
Study 35681155 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpyloric tube feeding
Number of subjects: 924
Study 35681155 — intervention group
Group type: COMPARATOR
Intervention: Gastric tube feeding
Number of subjects: 924
Study 32129795 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-report
Number of subjects: 8373
Study 32129795 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy fill data
Number of subjects: 8373
Study 32129795 — intervention group
Group type: EXPERIMENTAL
Intervention: Both patient self-report and pharmacy fill data
Number of subjects: 8373
Study 32129795 — intervention group
Group type: EXPERIMENTAL
Intervention: Criterion standard definition
Number of subjects: 8373
Study 32129795 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients nonpersistent by both methods
Number of subjects: 8373
Study 36203357 — intervention group
Group type: EXPERIMENTAL
Intervention: Site 1 (hand wrist)
Number of subjects: 94
Study 36203357 — intervention group
Group type: EXPERIMENTAL
Intervention: Site 2 (distal quarter of the forearm)
Number of subjects: 94
Study 36203357 — intervention group
Group type: EXPERIMENTAL
Intervention: Site 3 (midpoint of the forearm)
Number of subjects: 94
Study 34611132 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month lifestyle intervention
Number of subjects: 143
Study 34611132 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 143
Study 34611132 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary weight loss
Number of subjects: 143
Study 32087257 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 33 °C for 24 hours
Number of subjects: 349
Study 32087257 — intervention group
Group type: COMPARATOR
Intervention: Targeted temperature management (TTM) at 33 °C for 48 hours
Number of subjects: 349
Study 32087257 — intervention group
Group type: EXPERIMENTAL
Intervention: AKI stages 2 and 3
Number of subjects: 349
Study 32087257 — intervention group
Group type: EXPERIMENTAL
Intervention: AKI (overall)
Number of subjects: 349
Study 33278292 — intervention group
Group type: EXPERIMENTAL
Intervention: hfTENS
Number of subjects: 40
Study 33278292 — intervention group
Group type: COMPARATOR
Intervention: sham
Number of subjects: 40
Study 33502276 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped Learning (FL) in 2017 for Medical topics
Number of subjects: 404
Study 33502276 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped Learning (FL) in 2018 for the entire course
Number of subjects: 404
Study 33502276 — intervention group
Group type: COMPARATOR
Intervention: Traditional Lecture (TL) in 2016 for the entire course
Number of subjects: 404
Study 32293522 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root-planing treatment
Number of subjects: 40
Study 32293522 — intervention group
Group type: COMPARATOR
Intervention: Tooth-brushing (usual care)
Number of subjects: 40
Study 35142559 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (12 weeks, 3 days/week)
Number of subjects: 48
Study 35142559 — intervention group
Group type: COMPARATOR
Intervention: Nonaerobic exercise (control)
Number of subjects: 48
Study 35142559 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Aerobic and Control)
Number of subjects: 48
Study 34140144 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional-dose SRT (64 Gy)
Number of subjects: 350
Study 34140144 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-intensified SRT (70 Gy)
Number of subjects: 350
Study 32783554 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mSv CT
Number of subjects: 3074
Study 32783554 — intervention group
Group type: COMPARATOR
Intervention: Standard-Dose CT (SDCT)
Number of subjects: 3074
Study 36066168 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison between 500 IU/day and 1000 IU/day cholecalciferol
Number of subjects: 60
Study 32890573 — intervention group
Group type: EXPERIMENTAL
Intervention: SNP rs56151658 (test allele A)
Number of subjects: 34167
Study 32890573 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple SNPs in strong linkage disequilibrium with rs56151658
Number of subjects: 34167
Study 32890573 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA genes (HLA-DQA2, HLA-DRB6, HLA-DOB)
Number of subjects: 34167
Study 34404610 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic screening and feedback tool
Number of subjects: 302
Study 34404610 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 302
Study 33909361 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with psychological intervention
Number of subjects: 100
Study 33909361 — intervention group
Group type: COMPARATOR
Intervention: Routine psychological intervention (Control)
Number of subjects: 100
Study 35363318 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib 10 mg twice daily (n = 165)
Number of subjects: 329
Study 35363318 — intervention group
Group type: COMPARATOR
Intervention: Best available therapy (BAT) (n = 164)
Number of subjects: 329
Study 35363318 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Number of subjects: 329
Study 35363318 — intervention group
Group type: COMPARATOR
Intervention: BAT
Number of subjects: 329
Study 33992241 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-load-high-repetitions (LLHR) program
Number of subjects: 42
Study 33992241 — intervention group
Group type: COMPARATOR
Intervention: Pilates program
Number of subjects: 42
Study 35951014 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% EGCG (10 mg/kg daily dose)
Number of subjects: 73
Study 35951014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 33975579 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-guided SBRT
Number of subjects: 300
Study 33975579 — intervention group
Group type: COMPARATOR
Intervention: CT-guided SBRT
Number of subjects: 300
Study 35233908 — intervention group
Group type: EXPERIMENTAL
Intervention: ertugliflozin 5 mg
Number of subjects: 8246
Study 35233908 — intervention group
Group type: EXPERIMENTAL
Intervention: ertugliflozin 15 mg
Number of subjects: 8246
Study 35233908 — intervention group
Group type: EXPERIMENTAL
Intervention: ertugliflozin (pooled)
Number of subjects: 8246
Study 35233908 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 8246
Study 33587397 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (IN-OXT) 24 IU
Number of subjects: 0
Study 33587397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33096684 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent Energy Restriction (IER)
Number of subjects: 70
Study 33096684 — intervention group
Group type: COMPARATOR
Intervention: Continuous Energy Restriction (CER)
Number of subjects: 70
Study 616863419 — intervention group
Group type: EXPERIMENTAL
Intervention: Gymnema sylvestre (GS) treatment
Number of subjects: 51
Study 36131291 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (initiated at 500mg/day, titrated to a maximum of 2500mg over 10 days)
Number of subjects: 0
Study 36131291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36131291 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0
Study 32036242 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg of CBD (Epidiolex® or Epidyolex®) twice daily for 4 weeks followed by 2 weeks of 750 mg b.i.d. CBD (Part 2, Arm 1)
Number of subjects: 30
Study 32036242 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo (Part 2, Arm 2)
Number of subjects: 30
Study 32036242 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg of CBD (Epidiolex® or Epidyolex®)
Number of subjects: 30
Study 35361136 — intervention group
Group type: EXPERIMENTAL
Intervention: Dementia-friendly hospital program
Number of subjects: 423
Study 35361136 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 423